Possible buy in morning Nektar

[erwinmark]

Nektar (NKTR) has a very interesting business model, with many blockbuster drugs in the pipeline. Do your do diligence.

Many thought they were going to have huge anouncement today after the market close, but they had nothing new in call.


Down the road this could be a 50 dollars stock easy, just need time.

 

[erwinmark]

Sorry never dropped I guess the aftermark was a show put on by shorts, took off like a shot this morning! Good long term hold.

 

[kuwlness]

Sorry never dropped I guess the aftermark was a show put on by shorts, took off like a shot this morning! Good long term hold.

Wow, I looked at it in the AH and was wondering why the stock was trading down. Guess the MMs wanted to paint it down in AH just to get all the cheapies this morning in pre-market trading.

You didnt short it did you? Wasnt sure what you meant by "put on my shorts"

 

[erwinmark]

No, I have been in stock for a year or so, have ave. cost of about 6. I just thought it might offer a good entry point if you have a long term prospective. They have one of the best platforms for new drugs of any company.

 

[erwinmark]

Nice conference call, only a few new details about several new drugs Nektar 181 and 194.

I have to agree with Howard the CEO, everybody is looking for the magic pain pill, this will drive this company in the future.

I would sell the rights to all the cancer treatments, and leverage these two drugs. Look at the markets for Celebrex, etc., face it the babyboomers want to feel good at any cost.

 

[erwinmark]

Big ASCO cancer meeting next week, but data will be submitted Thursday evening, this stock could see a decent pop on news about Phase 2 study, after market closes, or Friday morning. FYI

 

[erwinmark]

News was very good, but who knows in this market it might not pop. Good luck if you happen to be long!

 

[erwinmark]

This could be positive for stock, they have a small piece of the profits of this drug.



Affymax® to Hold Conference Call and Webcast on Monday, June 21, 2010 at 8:00 a.m. Eastern Time

Press Release Source: Affymax, Inc. On Sunday June 20, 2010, 5:00 pm EDT
PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY - News) today announced that its management team will host a conference call and webcast tomorrow, Monday, June 21, 2010 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time).

Conference Call Details

To access the live conference call tomorrow, Monday, June 21, 2010 at 8:00 a.m. Eastern Time via phone, please dial 877-354-4057 from the United States and Canada or +1-224- 357-2391 internationally. The Conference ID is 83101977. Please dial in approximately ten minutes prior to the start of the call. Individuals interested in listening to the live call via webcast may do so by visiting www.affymax.com and clicking on the "Investor Relations" section. A replay of the webcast will be available on the Company's website for 30 days.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional information, please visit www.affymax.com.